For example, in breast cancer, one study showed that chemotherapy was associated with decreased serum HMGB1, which correlated with treatment efficacy [108], while a separate study demonstrated that complete loss of HMGB1 was linked to poor response [109]. This evidence concerns the gene HMGB1 and breast carcinoma.